Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial-Reference-Cited by-同舟云学术

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

Published:2017-02-28 Issue:2 Volume:14 Page:e1002248
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Snowdon Victoria K.,Lachlan Neil J.,Hoy Anna M.,Hadoke Patrick W. F.^ORCID,Semple Scott I.,Patel Dilip^ORCID,Mungall Will,Kendall Timothy J.^ORCID,Thomson Adrian^ORCID,Lennen Ross J.,Jansen Maurits A.^ORCID,Moran Carmel M.,Pellicoro Antonella,Ramachandran Prakash^ORCID,Shaw Isaac^ORCID,Aucott Rebecca L.,Severin Thomas,Saini Rajnish,Pak Judy^ORCID,Yates Denise,Dongre Neelesh,Duffield Jeremy S.,Webb David J.,Iredale John P.,Hayes Peter C.,Fallowfield Jonathan A.^ORCID

Funder

Academy of Medical Sciences

Wellcome Trust

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference46 articles.

1. International criteria for acute kidney injury: advantages and remaining challenges;NM Selby;PLoS Med,2016

2. Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis;P Angeli;Gut,2015

3. Intensive and critical care medicine: reflections, recommendations and perspectives;J Besso,2007

4. Prognostic importance of the cause of renal failure in patients with cirrhosis;M Martin-Llahi;Gastroenterology,2011

5. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites;A Krag;Gut,2010

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review article: Recent advances in ascites and acute kidney injury management in cirrhosis;Alimentary Pharmacology & Therapeutics;2024-03-25

2. Significance of plasma relaxin-2 levels in patients with primary hypertension and type 2 diabetes mellitus;Wiener Medizinische Wochenschrift;2024-03-07

3. Pathophysiology of Hepatorenal Syndrome;Advances in Kidney Disease and Health;2024-03

4. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?;World Journal of Gastroenterology;2024-01-14

5. Relaxin;Reference Module in Biomedical Sciences;2024